FMR LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,639,423
+4.7%
1,495,0000.0%0.00%
Q2 2023$2,520,331
-56.4%
1,495,000
-50.0%
0.00%
Q1 2023$5,776,414
-43.7%
2,990,000
-45.6%
0.00%
-100.0%
Q4 2022$10,264,660
+40.2%
5,495,000
+25.0%
0.00%0.0%
Q3 2022$7,324,000
-36.7%
4,395,000
-52.4%
0.00%0.0%
Q2 2022$11,567,000
-4.5%
9,235,0000.0%0.00%0.0%
Q1 2022$12,109,000
+95.2%
9,235,000
+118.1%
0.00%
Q4 2021$6,202,000
-1.0%
4,235,0000.0%0.00%
Q3 2021$6,263,000
+12.2%
4,235,0000.0%0.00%
Q2 2021$5,582,000
+0.9%
4,235,0000.0%0.00%
Q1 2021$5,532,000
-62.0%
4,235,000
-28.6%
0.00%
-100.0%
Q4 2020$14,551,000
+16.3%
5,935,000
-1.7%
0.00%0.0%
Q3 2020$12,514,000
-9.6%
6,035,0000.0%0.00%
-50.0%
Q2 2020$13,850,000
+9.5%
6,035,000
-27.6%
0.00%0.0%
Q1 2020$12,652,000
-48.1%
8,335,000
-33.5%
0.00%
-33.3%
Q4 2019$24,381,000
+126.8%
12,535,000
+54.1%
0.00%
+200.0%
Q3 2019$10,748,000
-58.0%
8,135,000
-29.2%
0.00%
-66.7%
Q2 2019$25,576,000
+29.0%
11,490,000
+4.5%
0.00%
+50.0%
Q1 2019$19,830,00010,990,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 92,999,000$138,298,0004.13%
WOLVERINE ASSET MANAGEMENT LLC 84,505,000$125,210,0001.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 20,000,000$29,789,0000.79%
Verition Fund Management LLC 27,047,000$40,063,0000.35%
ADVENT CAPITAL MANAGEMENT /DE/ 7,970,000$11,789,0000.22%
Baker Brothers Advisors 29,174,000$43,167,0000.19%
Calamos Advisors LLC 23,631,000$35,035,0000.15%
RWC Asset Management LLP 2,900,000$4,300,0000.13%
Aequim Alternative Investments LP 1,957,000$2,899,0000.11%
PALISADE CAPITAL MANAGEMENT, LP 3,148,000$4,666,0000.10%
View complete list of SAREPTA THERAPEUTICS INC shareholders